Literature DB >> 4166592

The preparation of plasmin treated immune serum globulin for intravenous use.

J T Sgouris.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1967        PMID: 4166592

Source DB:  PubMed          Journal:  Vox Sang        ISSN: 0042-9007            Impact factor:   2.144


× No keyword cloud information.
  9 in total

Review 1.  New and old aspects of immunoglobulin application. The use of intravenous IgG as prophylaxis and for treatment of infections.

Authors:  L Hammarström; C I Smith
Journal:  Infection       Date:  1990 Sep-Oct       Impact factor: 3.553

2.  [Crystallization of the Fc fragment from human IgG globulin obtained with plasmin].

Authors:  H Haupt; K Heide
Journal:  Klin Wochenschr       Date:  1969-03-01

3.  [Problems of intravenous gammaglobulin therapy (author's transl)].

Authors:  J Ring; K H Duswald
Journal:  Klin Wochenschr       Date:  1980-08-15

4.  Protective effects of S-sulfonated human gamma globulin against experimental infections in mice.

Authors:  H Tomioka; Y Iwamura; Y Suzuki; S Ohtomo; Y Hashimoto
Journal:  Infect Immun       Date:  1980-11       Impact factor: 3.441

Review 5.  [Therapeutic use of immunoglobulins in children (author's transl)].

Authors:  W H Hitzig
Journal:  Blut       Date:  1980-03

6.  Antipyretic activity of a human immunoglobulin preparation for intravenous use in an experimental model of fever in rabbits.

Authors:  M Iwata; T Shimozato; H Tokiwa; E Tsubura
Journal:  Infect Immun       Date:  1987-03       Impact factor: 3.441

7.  [Tolerance of a new intravenously applied immunoglobulin preparation and its effect on serum globulin levels].

Authors:  W Hansi; H Heimpel; S Barandun; O Lutz
Journal:  Infection       Date:  1982 Nov-Dec       Impact factor: 3.553

8.  Intravenous immunoglobulin therapy for antibody deficiency.

Authors:  M T Nolte; B Pirofsky; G A Gerritz; B Golding
Journal:  Clin Exp Immunol       Date:  1979-05       Impact factor: 4.330

Review 9.  Intravenous immunoglobulins: evolution of commercial IVIG preparations.

Authors:  John A Hooper
Journal:  Immunol Allergy Clin North Am       Date:  2008-11       Impact factor: 3.479

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.